Skip to main content
. 2023 Nov 3;15(21):4656. doi: 10.3390/nu15214656

Table 3.

Anthropometric and clinical data of participants at baseline, T6, and T12.

Variable Baseline T6 T12 p-Value a
Weight (Kg) 93.0 (78.0–103.0) 92.0 (79.0–101.0) * 91.5 (79.5–104.0) * 0.002
BMI (kg/m2) 31.8 (28.1–37.8) 33.7 (27.9–37.2) * 30.4 (26.1–36.1) * 0.002
Waist circumference (cm) 108.5 (100.0–118.0) 107.0 (97.0–113.0) 109.0 (93.0–116.0) 0.152
Hip circumference (cm) 113.0 (104.0–126.0) 114.5 (101.5–123.0) 112.0 (99.0–120.0) 0.452
WHR 1.0 (0.9–1.0) 1.1 (1.0–1.1) 0.9 (0.9–1.0) 0.178
Systolic blood pressure (mmHg) 130.0 (110.0–150.0) 130.0 (120.0–140.0) 125.0 (120.0–137.5) 0.717
Diastolic blood pressure (mmHg) 80.0 (70.0–90.0) 80.0 (75.0–85.0) 80.0 (70.0–80.0) 0.494
PREDIMED 7.0 (7.0–8.0) 9.0 (9.0–10.0) * 8.5 (8.0–10.0) * 0.002
PREDIMED CLASS 0.301
- No adherence 5.3% 0.0% 0.0%
- Adherence 78.9% 58.8% 72.2%
- Max adherence 15.8% 41.2% 27.8%
IPAQ 0.318
- Low 52.6% 29.4% 22.2%
- Moderate 31.6% 47.1% 38.9%
- High 15.8% 23.5% 38.9%
Fasting blood glucose (mg/dL) 115.0 (105.0–140.0) 107.0 (102.0–108.0) 110.0 (102.0–125.0) 0.223
Hba1c 6.5 (5.9–7.5) 6.1 (6.0–6.3) 6.3 (5.5–6.7) 0.350
Total cholesterol (mg/dL) 199.0 (183.0–217.5) 208.5 (197.0–238.5) 193.0 (160.0–223.0) 0.751
HDL (mg/dL) 41.0 (37.0–55.0) 48.5 (41.0–55.0) 46.0 (41.0–51.0) 0.135
TG (mg/dL) 139.5 (93.5–214.5) 118.5 (94.5–187.5) 120.4 (96.0–160.7) 0.900
LDL (mg/dL) 120.4 (101.2–138.0) 132.7 (121.6–160.7) 123.8 (90.8–137.0) 0.913

n (%) or median and interquartile range (IQR) are shown when appropriate. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides. a p-values are for Pearson’s chi-square test or Friedman test; * p-value < α/3 for Bonferroni multiple testing correction vs. Baseline. Statistically significant values are given in bold.